Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

124.81
Delayed Data
As of May 22
 -0.07 / -0.06%
Today’s Change
51.93
Today|||52-Week Range
132.99
+28.67%
Year-to-Date

Today’s Trading

Previous close124.88
Today’s open124.54
Day’s range122.28 - 125.18
Volume378,167
Average volume (3 months)701,979
Market cap$10.5B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book10.29

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.99+1.44%
ISISIsis Pharmaceuticals...+0.59+0.88%
ICLRICON PLC-0.77-1.15%
DYAXDyax Corp-0.06-0.22%
Data as of 4:03pm ET, 05/22/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers